Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Signet Therapeutics

  1. Home
  2. Signet Therapeutics
By jpalfreyman on Wed, 02/26/2025 - 09:03
ClinicalTrials.gov URL
https://clinicaltrials.gov/study/NCT06739291?term=SIGX1094R&rank=1
EA Page
https://www.signettx.com/news-information/120.html
Sponsor
Signet Therapeutics
EA Therapies for Single Patient

Available Early Access Program
SIGX1094: Diffuse Gastric Cancer

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA